Cargando…
Association of Discontinuing Preinjury Beta-Adrenergic Blockade Medications With Mortality in Severe Blunt Traumatic Brian Injury
BACKGROUND: Beta-adrenergic receptor blocker (BB) administration has been shown to improve survival after traumatic brain injury (TBI). However, studies to date that observe a benefit did not distinguish between continuation of preinjury BB versus de novo initiation of BB. OBJECTIVES: To determine t...
Autores principales: | Tignanelli, Christopher J., Arbabi, Saman, Iskander, Gaby, Kralovich, Kurt, Scott, John, Sangji, Naveen F., Hemmila, Mark R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513140/ https://www.ncbi.nlm.nih.gov/pubmed/37746607 http://dx.doi.org/10.1097/AS9.0000000000000324 |
Ejemplares similares
-
Beta-Adrenergic Blockade in Critical Illness
por: Bruning, Rebecca, et al.
Publicado: (2021) -
Beta adrenergic blockade reduces utilitarian judgement
por: Sylvia, Terbeck, et al.
Publicado: (2013) -
The Brian Simulator
por: Goodman, Dan F. M., et al.
Publicado: (2009) -
Brian Charlesworth
por: Charlesworth, Brian
Publicado: (2020) -
Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022)